NO861483L - Fremgangsmaate for aa isolere en terapeutisk nyttig stamme av lactobacillus acidophilus. - Google Patents

Fremgangsmaate for aa isolere en terapeutisk nyttig stamme av lactobacillus acidophilus.

Info

Publication number
NO861483L
NO861483L NO861483A NO861483A NO861483L NO 861483 L NO861483 L NO 861483L NO 861483 A NO861483 A NO 861483A NO 861483 A NO861483 A NO 861483A NO 861483 L NO861483 L NO 861483L
Authority
NO
Norway
Prior art keywords
bacteria
lactobacillus acidophilus
strain
isolating
procedure
Prior art date
Application number
NO861483A
Other languages
English (en)
Other versions
NO169241C (no
NO169241B (no
Inventor
Sherwood L Gorbach
Barry R Goldin
Original Assignee
New England Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24909071&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO861483(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by New England Medical Center Inc filed Critical New England Medical Center Inc
Publication of NO861483L publication Critical patent/NO861483L/no
Publication of NO169241B publication Critical patent/NO169241B/no
Publication of NO169241C publication Critical patent/NO169241C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Dairy Products (AREA)
NO861483A 1985-04-17 1986-04-16 Fremgangsmaate for aa isolere en terapeutisk anvendbar stamme av lactobacillus acidophilus NO169241C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/724,114 US4839281A (en) 1985-04-17 1985-04-17 Lactobacillus strains and methods of selection

Publications (3)

Publication Number Publication Date
NO861483L true NO861483L (no) 1986-10-20
NO169241B NO169241B (no) 1992-02-17
NO169241C NO169241C (no) 1992-05-27

Family

ID=24909071

Family Applications (1)

Application Number Title Priority Date Filing Date
NO861483A NO169241C (no) 1985-04-17 1986-04-16 Fremgangsmaate for aa isolere en terapeutisk anvendbar stamme av lactobacillus acidophilus

Country Status (9)

Country Link
US (2) US4839281A (no)
EP (1) EP0199535B2 (no)
JP (1) JPH0648979B2 (no)
AT (1) ATE71140T1 (no)
AU (1) AU597882B2 (no)
DE (1) DE3683184D1 (no)
DK (1) DK171369B1 (no)
FI (1) FI90086C (no)
NO (1) NO169241C (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104219968A (zh) * 2012-03-23 2014-12-17 Mjn美国控股有限责任公司 用于预防和治疗感染的益生菌来源的无活力的材料

Families Citing this family (158)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
US4946791A (en) * 1986-10-02 1990-08-07 Bio Techniques Laboratories, Inc. Novel strain of Lactobacillus acidophilus
US4980164A (en) * 1986-10-02 1990-12-25 Bio Techniques Laboratories, Inc. Strains of lactobacillus for enhancing feed conversion efficiency
CH674150A5 (no) * 1987-10-30 1990-05-15 2 Oi Mo G Med I Im N I Pirogov
DK686187D0 (da) * 1987-12-23 1987-12-23 Hansens Chr Bio Syst Veterinaert praeparat
AU3836489A (en) * 1988-06-09 1990-01-05 Whitecliffe Laboratories Limited Treatment of immunodeficiency
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
AU630277B2 (en) * 1990-01-31 1992-10-22 San-Ei Sucrochemical Co., Ltd. Lactobacillus acidophilus f-133, lactic acid bacterium preparation prepared therefrom, and process for preparing the same
US5139792A (en) * 1990-07-19 1992-08-18 Bio-Techniques Laboratories, Inc. Method and system for dispensing live bacteria into animal feed and drinking water
SE469875C (sv) * 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
US5256425A (en) * 1991-08-19 1993-10-26 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
US5179020A (en) * 1991-08-19 1993-01-12 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
EP0577903B1 (fr) * 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
EP0768375B2 (fr) * 1992-07-06 2002-06-12 Societe Des Produits Nestle S.A. Bactérie lactique
US5413785A (en) * 1993-01-27 1995-05-09 New England Deaconess Hospital Corp. Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo
US6156320A (en) * 1993-02-05 2000-12-05 Harry Parsekian Fermented milk nutraceuticals
RU2031586C1 (ru) 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
CA2156859A1 (en) * 1993-02-24 1994-09-01 Sherwood L. Gorbach Method of enhancing immune response to oral vaccines
JP2824821B2 (ja) * 1993-11-04 1998-11-18 カルピス株式会社 乳酸菌及び発酵乳製品
US5434765A (en) * 1994-03-10 1995-07-18 Holophane Corporation Luminaire assembly
JP2992945B2 (ja) * 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌
CA2191213C (en) * 1994-05-26 2008-03-18 Lorenzo Morelli Lactobacillus strains of human origin, their compositions and uses thereof
US6036669A (en) 1995-01-13 2000-03-14 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
US5533973A (en) * 1995-01-13 1996-07-09 Abbott Laboratories Alteration of nutritional product during enteral tube feeding
US6277092B1 (en) 1995-01-13 2001-08-21 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
IT1276783B1 (it) * 1995-06-23 1997-11-03 Bracco Spa Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
FR2740471B1 (fr) * 1995-10-31 1997-12-19 Gervais Danone Co Ferments lactiques, et leur utilisation pour l'obtention de produits hypocholesterolemiants
AT405235B (de) * 1995-11-02 1999-06-25 Helmut Dr Viernstein Probiotisch wirksame formulierung
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
DE69733594T2 (de) * 1996-07-09 2005-11-03 Société des Produits Nestlé S.A. Verfahren zur Sprühtrocknung
IT1284877B1 (it) * 1996-08-09 1998-05-22 Dicofarm Spa Trattamento delle diarree acute del bambino e prevenzione della sensibilizzazione allergica verso alimenti introdotti nella fase
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
IL128791A (en) * 1996-09-06 2001-10-31 Nestle Sa Ice cream
GB9623068D0 (en) * 1996-11-06 1997-01-08 Cultech Limited Microflora
AU5113798A (en) 1996-11-29 1998-06-22 Bio K & International Inc. Lactic ferment comprising a particular strain of (lactobacillus acidophilus) and use thereof
EP1728855A1 (en) * 1996-11-29 2006-12-06 Bio-K Plus International, Inc. Lactic ferment comprising a particular strain of lactobacillus acidopuilus and use thereof
ES2360341T3 (es) * 1997-02-11 2011-06-03 Enterprise Ireland (Trading As Bioresearch Ireland) Cepas probióticas de lactobacillus salivarius y agentes antimicrobianos obtenidos a partir de las mismas.
US6093394A (en) 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
IL133543A (en) 1997-07-05 2003-10-31 Nestle Sa Frozen dessert
US6080132A (en) * 1998-02-27 2000-06-27 Abbott Laboratories Apparatus for altering characteristics of a fluid
US7029702B2 (en) 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
EP1159951A1 (en) * 2000-06-02 2001-12-05 Societe Des Produits Nestle S.A. Use of exogenous lactic bacteria strain against Actinomyces naeslundii-related diseases
TR200100406T2 (tr) * 1998-08-12 2001-12-21 Societe Des Produits Nestle S.A. Ağız mikroflorası içine egzojen laktik bakteri yerleştirilmesi
FR2785809B1 (fr) 1998-11-18 2001-01-12 Gervais Danone Sa Selection et utilisations de souches de bacteries lactiques modulatrices de l'immunite non-specifique
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
IT1312098B1 (it) * 1999-04-23 2002-04-04 Proge Farm Srl Metodo di selezione di ceppi di lattobacilli adesivi con proprieta'terapeutiche e ceppi ottenuti con tale metodo.
US20040197352A1 (en) * 1999-04-30 2004-10-07 Natarajan Ranganathan Methods of improving or augmenting kidney function
US7998470B2 (en) * 1999-04-30 2011-08-16 Kibow Biotech, Inc. Compositions and methods improving renal function
US6706287B2 (en) 2001-05-15 2004-03-16 Kibow Biotech Inc. Prebiotic and probiotic compositions and methods for their use in gut-based therapies
RU2146454C1 (ru) * 1999-05-18 2000-03-20 Анисимова Таисия Ивановна Штамм бактерий lactobacillus acidophilus n.v.ep 317/402 "наринэ" ааа, используемый при приготовлении препаратов, диетических и лечебно-профилактических продуктов для лечения дисбактериоза и его последствий
IL130303A0 (en) 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
US6251432B1 (en) 1999-07-01 2001-06-26 Abbott Laboratories Sustained release dosage form unit having latex coating and method of making the same
DE19963104A1 (de) * 1999-12-24 2001-06-28 Ralf Kirkamm Mittel zur Behandlung von Bakterienmangel
JP2003535903A (ja) * 2000-06-19 2003-12-02 ミューコプロテック・プロプライエタリー・リミテッド プロバイオティックを用いた、粘膜表面での細菌またはウイルス感染の免疫療法または治療、およびそのための組成物
IT1320772B1 (it) * 2000-11-02 2003-12-10 Proge Farm Srl Composizione farmaceutica a base di agenti attivi contro la candidaper il trattamento di disturbi della mucosa orale e intestinale
NZ526443A (en) 2000-12-18 2005-03-24 Probiohealth Llc Probiotic compounds derived from lactobacillus casei strain KE01
US7214370B2 (en) 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
RU2176668C1 (ru) * 2001-01-04 2001-12-10 Федеральное Государственное унитарное предприятие научно-производственное объединение "Вирион" ШТАММ БАКТЕРИЙ LACTOBACILLUS ACIDOPHILUS N.V.EP 317/402 "НАРИНЭ" ТНСи, ИСПОЛЬЗУЕМЫЙ ПРИ ПРИГОТОВЛЕНИИ ЛЕЧЕБНО-ПРОФИЛАКТИЧЕСКИХ ПРЕПАРАТОВ ДЛЯ НОРМАЛИЗАЦИИ КИШЕЧНОЙ МИКРОФЛОРЫ
FI109602B (fi) 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
US7060687B2 (en) * 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
RU2203946C1 (ru) * 2001-09-12 2003-05-10 Хачатрян Ашот Папикович Штамм бактерий lactobacillus acidophilus n.v. ep 317/402-x "баланс-наринэ", используемый для приготовления противогастритного и противоязвенного кисломолочного продукта
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
DK1485463T3 (da) * 2002-03-21 2008-11-10 Bifodan As Lactobacillus stamme
US7300787B2 (en) * 2002-07-05 2007-11-27 Archer-Daniels-Midland Company Lactobacillus strains and use thereof in fermentation for L-lactic acid production
JP4618970B2 (ja) * 2002-08-02 2011-01-26 マルホ株式会社 肛門圧低下外用剤
TWI241912B (en) * 2002-10-30 2005-10-21 Food Industry Res & Dev Inst Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
FI113057B (fi) * 2002-11-04 2004-02-27 Valio Oy Menetelmä hiivojen kasvun estämiseksi
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
PT1631431T (pt) 2003-05-22 2017-07-24 Propex Operating Co Llc Processo para fabrico de artigos poliméricos
WO2005032591A1 (en) 2003-09-30 2005-04-14 Kibow Biotech, Inc. Compositions and methods for augmenting kidney function
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
EP1744767A4 (en) * 2004-04-20 2008-08-13 Univ Chicago THERAPEUTIC DELIVERY SYSTEM WITH PEG-LIKE CONNECTION WITH HIGH MOLECULAR WEIGHT
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
US20060003454A1 (en) * 2004-07-02 2006-01-05 Conjugon, Inc. Non-dividing donor cells for gene transfer
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
FR2875406B1 (fr) * 2004-09-21 2007-01-05 Danisco Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal
ES2348403T3 (es) * 2005-02-15 2010-12-03 Barry R. Goldin Un alimento que contiene un probiotico y un beta-glucano aislado y metodos de uso del mismo.
WO2006108824A1 (en) 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060270040A1 (en) * 2005-05-26 2006-11-30 Conjugon, Inc. Compositions and methods for treating tissue
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
ATE512211T1 (de) 2005-05-31 2011-06-15 Iams Company Feline probiotische lactobacilli
EP2604689B1 (en) 2005-07-26 2015-01-21 Nestec Ltd. Anti-obesity agent and anti-obesity food
DK3067057T3 (da) 2005-09-28 2023-02-13 Nordic Rebalance As Probiotisk fermenteret cerealiesammensætninger til anvendelse ved behandling af gastrointestinale lidelser forårsaget af pro-inflammatoriske bakterier
CA2642431A1 (en) 2006-02-15 2007-08-23 Nestec S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
CA2644968A1 (en) 2006-03-07 2007-09-13 Nestec S.A. Synbiotic mixture
PL1993577T3 (pl) 2006-03-10 2014-07-31 Nutricia Nv Stosowanie nieulegających trawieniu sacharydów dla zapewnienia niemowlęciu najlepszego startu po narodzinach
AU2013201783B2 (en) * 2006-10-02 2015-06-04 International N&H Denmark Aps Probiotics for use in reducing the incidence and duration of illness
US7387427B2 (en) * 2006-10-20 2008-06-17 Bristol-Myers Squibb Company Method for blending heat-sensitive material using a conical screw blender with gas injection
US20080095752A1 (en) * 2006-10-20 2008-04-24 Win-Chin Chiang Method for extending the shelf-life of powdered nutritional formulations which contain viable probiotics
EP2124966B1 (en) 2007-02-01 2015-09-09 IAMS Europe B.V. Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
EP1974735A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
PL2244593T3 (pl) 2008-01-24 2015-11-30 Nestec Sa Kapsułka zawierająca składniki odżywcze i sposób dostarczania cieczy odżywczej z kapsułki
FI121912B (fi) * 2008-02-05 2011-06-15 Valio Oy Probioottien uusi käyttö
SG188887A1 (en) 2008-03-14 2013-04-30 Nestec Sa Synbiotic mixture
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
KR101782170B1 (ko) 2009-02-02 2017-09-26 시에이치알. 한센 에이/에스 락토바실러스 람노서스 필루스 폴리펩티드 및 그 생산방법
SG173832A1 (en) 2009-02-24 2011-09-29 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
FI121952B (fi) 2009-05-06 2011-06-30 Oriola Oy Menetelmä pisaroina annosteltavan terveystuotteen valmistamiseksi
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
GB0914878D0 (en) 2009-08-26 2009-09-30 Plant Bioscience Ltd Competetive exclusion compositions and methods
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
US20110070334A1 (en) 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
US20140093614A1 (en) 2009-09-20 2014-04-03 Mead Johnson Nutrition Company Probiotic stabilization
FI20096058A0 (fi) 2009-10-13 2009-10-13 Valio Oy Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
AU2010329990B2 (en) 2009-12-08 2015-07-16 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
EP2563372A4 (en) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc PREBIOTIC FORMULATIONS AND METHODS OF USE
WO2011141762A1 (en) 2010-05-12 2011-11-17 Compagnie Gervais Danone Synergistic fermentation of lactobacillus rhamnosus and lactobacillus paracasei subsp paracasei
US9474298B2 (en) 2011-10-11 2016-10-25 Mead Johnson Nutrition Company Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies
JP6203816B2 (ja) 2012-03-29 2017-09-27 セラバイオーム，エルエルシー 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
GB201206599D0 (en) 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
US20130344042A1 (en) 2012-06-20 2013-12-26 Gretchen Tanbonliong Dietary management of celiac disease and food allergy
KR102324015B1 (ko) * 2012-09-25 2021-11-10 아퀼론 씨와이엘 에스.엘. 프로바이오틱 및 프리바이오틱 조성물
CA3212215A1 (en) 2012-11-23 2014-05-30 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
CA2899925A1 (en) 2013-02-04 2014-08-07 Seres Therapeutics, Inc. Compositions and methods for inhibition of pathogenic bacterial growth
HK1218560A1 (zh) 2013-02-04 2017-02-24 Seres Therapeutics, Inc. 组成与方法
AU2014239883B2 (en) 2013-03-14 2019-01-17 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
EP2967077A4 (en) 2013-03-15 2016-09-14 Seres Therapeutics Inc NETWORK-BASED MICROBIAL COMPOSITIONS AND METHOD
WO2015026235A2 (en) 2013-08-22 2015-02-26 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Production of probiotics by in vitro enrichment of beneficial microorganisms from human or animal microbiota
EP3074027B1 (en) 2013-11-25 2024-12-18 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
US20150305359A1 (en) * 2014-04-24 2015-10-29 Mead Johnson Nutrition Company Nutritional compositions directed to subjects having cow's milk protein allergies
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
CN115252650A (zh) 2015-11-03 2022-11-01 布里格姆及妇女医院股份有限公司 用于治疗和/或预防食物变态反应的治疗性微生物群
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
SG11201803121WA (en) 2015-11-09 2018-05-30 Mjn Us Holdings Llc Nutritional compositions comprising lactobacillus rhamnosus gg, as well as dietary butyrate and/or a compound for stimulating formation of endogenous butyrate
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
ES2965306T3 (es) 2016-12-16 2024-04-12 Gervais Danone Sa Composición probiótica que comprende cepas de Lactobacillus rhamnosus y Lactobacillus paracasei
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
DE102017113263A1 (de) 2017-06-16 2018-12-20 Lactopia GmbH Pharmazeutische Zusammensetzung enthaltend Bakterienstämme aus der Familie der Lactobacillaceae und Molke
EP3668527A1 (en) 2017-08-14 2020-06-24 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
JP2021501185A (ja) 2017-10-30 2021-01-14 セレス セラピューティクス インコーポレイテッド 抗生物質耐性を処置するための組成物及び方法
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
US12150968B2 (en) 2018-09-10 2024-11-26 L'oreal S.A. Method for reducing the transfer of pathogenic microorganisms
WO2020127637A1 (en) 2018-12-21 2020-06-25 Lactobio Aps Topical composition comprising viable microorganisms
CA3123125A1 (en) 2019-01-04 2020-05-22 Lactobio A/S Strains, composition and method of use
AU2020279533A1 (en) 2019-05-20 2021-12-23 L'ORéAL S.A. Composition for treatment, alleviation or prophylaxis of acne
CN114007434A (zh) 2019-06-05 2022-02-01 森永乳业株式会社 营养组合物
CN114245748A (zh) 2019-06-13 2022-03-25 莱托生物股份有限公司 包含活微生物的凝胶组合物
CN114144078B (zh) 2019-07-23 2024-06-11 菲仕兰坎皮纳荷兰公司 包含乳脂肪和免疫球蛋白的营养组合物
EP4719327A1 (en) 2023-05-30 2026-04-08 L'oreal Topical formulation comprising deliquescent substance
WO2025036982A1 (en) 2023-08-16 2025-02-20 L'oréal New container, method and delivery system stabilizing topical formulations
WO2025186365A1 (en) 2024-03-07 2025-09-12 L'oréal Cosmetic powder formulation comprising viable microorganisms

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU44002A1 (no) 1962-07-19 1963-09-03
NL294835A (no) 1962-07-19 1900-01-01
DE1617755A1 (de) * 1966-10-21 1972-02-17 Rehm Eberhard Verfahren zur Herstellung eines durch selektive Zuechtung von Laktobakterien erhaltenen Praeparates
GB1167196A (en) * 1966-12-12 1969-10-15 Yakult Honsha Kk Lactic Acid Bacteria.
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
IT1141095B (it) * 1980-11-27 1986-10-01 Ravizza Spa Processo di risoluzione della sulpiride racema
US4525351A (en) * 1983-01-11 1985-06-25 Chr. Hansen's Laboratory, Inc. Liquid adherent disinfectant compositions for topical application and method of preparation
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104219968A (zh) * 2012-03-23 2014-12-17 Mjn美国控股有限责任公司 用于预防和治疗感染的益生菌来源的无活力的材料

Also Published As

Publication number Publication date
FI860194L (fi) 1986-10-18
JPS61280433A (ja) 1986-12-11
EP0199535A2 (en) 1986-10-29
NO169241C (no) 1992-05-27
JPH0648979B2 (ja) 1994-06-29
DK171369B1 (da) 1996-09-30
FI860194A0 (fi) 1986-01-16
DK170186A (da) 1986-10-18
ATE71140T1 (de) 1992-01-15
FI90086B (fi) 1993-09-15
EP0199535B1 (en) 1992-01-02
AU597882B2 (en) 1990-06-14
US5032399A (en) 1991-07-16
EP0199535A3 (en) 1988-08-03
FI90086C (fi) 1993-12-27
AU5611286A (en) 1987-10-22
DE3683184D1 (de) 1992-02-13
DK170186D0 (da) 1986-04-15
NO169241B (no) 1992-02-17
US4839281A (en) 1989-06-13
EP0199535B2 (en) 1995-11-02

Similar Documents

Publication Publication Date Title
NO861483L (no) Fremgangsmaate for aa isolere en terapeutisk nyttig stamme av lactobacillus acidophilus.
CA2099855C (en) Antigastritis agent
FI931260A0 (fi) I tjocktarmen koloniserande lactobacillus-stammar
DK0768375T3 (da) Mælkesyrebakterier
DE3163243D1 (en) Process for the production of a bacterial preparation for the prophylaxis of intestinal disturbances in poultry
CA2263954A1 (en) Dehydrated food containing lactic acid bacteria
SU1692021A3 (ru) Способ получения лечебно-профилактического препарата для нормализации микрофлоры кишечника на основе бактерий рода bifidobacterium
JPS56140888A (en) Preparation of limiting enzyme
JPS57212122A (en) Antitumor agent and its preparation
JPS6486854A (en) Preparation of stable 'natto' resistant to secondary fermentation at normal temperature
SU1398398A1 (ru) Способ получения убихинонов
UA23320A (uk) Штам бактерій віfіdовастеrіuм lоnguм, який використовується у виробhицтві бактеріальhих препаратів та фермеhтоваhих молочhих продуктів
JPS5550896A (en) Preparation of antibiotic substance xk-62-5